Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: Histologic and immunohistochemical effects

Journal of the American Academy of Dermatology

Volumn 50, Issue 2, 2004, Pages 189-196

  Smit, Jürgen V ^a,b   De Sévaux, Ruud G L ^a,b   Blokx, Willeke A M ^a,b   Van De Kerkhof, Peter C M ^a,b   Hoitsma, Andries J ^a,b   De Jong, Elke M G J ^a,b  

^a University Medical Center ^*

^b University Medical Center

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN;

ACTINIC KERATOSIS; ADULT; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DYSPLASIA; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; KERATINIZATION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; PRECANCER; PRIORITY JOURNAL; RECURRENT DISEASE; SCORING SYSTEM; SKIN CANCER; SKIN INFLAMMATION; SQUAMOUS CELL CARCINOMA; STRATUM CORNEUM;

EID: 0842332469     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(03)01837-1     Document Type: Article

References (27)

1. Dreno B, Mansat E, Legoux B, Litoux P. Skin cancers in transplant patients. Nephrol Dial Transplant 1998;13:1374-9.
2. Cohen EB, Komorowski PA, Clowry LJ. Cutaneous complications in renal transplant recipients. Am J Clin Pathol 1987;88:32-7.
3. Sheil AG. Malignancy following liver transplantation: A report from the Australian Combined Liver Transplant Registry. Transplant Proc 1995;27:1247.
4. Barr BB, Benton EC, McLaren K, Bunney MH, Smith IW, Blessing K, et al. Papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1989;2:224-5.
5. Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol 2000;42:23-4.
6. Walder BK, Robertson MR, Jeremy D. Skin cancer and immunosuppression. Lancet 1971;2:1282-3.
7. Bavinck JN, Tieben LM, Van derWoude FJ, Tegzess AM, Hermans J, ter Schegget J, et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: A double-blind, placebo-controlled study. J Clin Oncol 1995;13:1933-8.
8. Gibson GE, O'Grady A, Kay EW, Murphy GM. Low-dose retinoid therapy for chemoprophylaxis of skin cancer in renal transplant recipients. J Eur Acad Dermatol Venereol 1998;10:42-7.
9. Kelly JVV, Sabto J, Gurr FW, Bruce F. Retinoids to prevent skin cancer in organ transplant recipients. Lancet 1991;338:1407.
10. Shuttleworth D, Marks R, Griffin PJ, Salaman JR. Treatment of cutaneous neoplasia with etretinate in renal transplant recipients. Q J Med 1988;68:717-25.
11. McKenna DB, Murphy GM. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol 1999;140:656-60.
12. Rook AH, Jaworsky C, Nguyen T, Grossman PA, Wolfe JT, Witmer WK, et al. Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Transplantation 1995;59:714-9.
13. Gibson GE, O'Grady A, Kay EW, Leader M, Murphy GM. Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy. J Eur Acad Dermatol Venereol 1998;10:130-6.
14. Smack DP, Korge BP, James WD. Keratin and keratinization. J Am Acad Dermatol 1994;30:85-102.
15. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
16. Watanabe S, Ichikawa E, Takahashi H, Otsuka F. Changes of cytokeratin and involucrin expression in squamous cell carcinomas of the skin during progression to malignancy. Br J Dermatol 1995;132:730-9.
17. Bauer FW. Cell kinetics. In: Textbook of psoriasis. Mier PD, van de Kerkhof PCM, editors, ed 1. New York, Churchill Livingstone, 1986.
18. Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000;42:11-7.
19. Kopan R, Traska G, Fuchs E. Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keratinization. J Cell Biol 1987;105:427-40.
20. Shimizu T, Oga A, Murakami T, Muto M. Overexpression of p53 protein associated with proliferative activity and histological degree of malignancy in solar keratosis. Dermatology 1999;199:113-8.
21. Onodera H, Nakamura S, Sugai T. Cell proliferation and p53 protein expressions in cutaneous epithelial neoplasms. Am J Dermatopathol 1996;18:580-8.
22. Kuijpers AL, Van Pelt JP, Bergers M, Boegheim PJ, Den Bakker JE, Siegenthaler G, et al. The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin. Br J Dermatol 1998;139:380-9.
23. Elias PM. Retinoid effects on the epidermis. Dermatologica 1987;175(suppl 1):28-36.
24. Korge B, Stadler R, Mischke D. Effect of retinoids on Hyperproliferation-associated keratins K6 and K16 in cultured human keratinocytes: a quantitative analysis. J Invest Dermatol 1990;95:450-5.
25. Rosenthal DS, Roop DR, Huff CA, Weiss JS, Ellis CN, Hamilton T, et al. Changes in photo-aged human skin following topical application of all-trans retinoic acid. J Invest Dermatol 1990;95:510-5.
26. Blokx WA, Smit JV, de Jong EM, Link MM, Van de Kerkhof PC, Ruiter DJ. Retinoids strongly and selectively correlate with keratin 13 and not keratin 19 expression in cutaneous warts of renal transplant recipients. Arch Dermatol 2002;138:61-5.
27. Agarwal C, Rorke EA, Boyce M, Howard J, Crish J, Hufeisen S, et al. Retinoid-dependent transcriptional suppression of cytokeratin gene expression in human epidermal squamous cell carcinoma cells. Differentiation 1993;52:185-91.